MeiraGTx Holdings plc Other Non-Current Liabilities
MeiraGTx Holdings plc (MGTX) had Other Non-Current Liabilities of $181.51 thousand as of 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2018-11-08
- 2018-09-30: Other Liabilities, Noncurrent $181.51K.
- 2018-06-30: Other Liabilities, Noncurrent $180.35K.
- 2017-12-31: Other Liabilities, Noncurrent $178.42K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2018-09-30 | $181.51K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $180.35K 10-Q · filed 2018-08-08 |
| 2017-12-31 | $178.42K 10-Q · filed 2018-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |